ANAHEIM, Calif.—Men with androgen independent prostate cancer (AIPC) who have received initial treatment with sipuleucel-T (Provenge) followed by docetaxel after progression of their disease may have prolonged survival, according to new findings presented here at the American Urological Association annual meeting.
QUEBEC CITY—A Canadian study of men with erectile dysfunction (ED) following prostate cancer therapy showed that those who received radiation therapy alone had greater success with ED treatment than men treated with radical prostatectomy alone or in combination with radiation.
QUEBEC CITY—Two Canadian studies characterizing the natural history of renal masses in elderly patients—many with significant comorbidities—may help to define when active surveillance is appropriate management in this population.
ANAHEIM, Calif.—Declines in prostate cancer deaths are associated with an increase in PSA screening, although the effect is greater in white than in black men, according to researchers at the University of Alabama-Birmingham.
Caps on malpractice awards to plaintiffs for noneconomic damages result in lower insurance premiums for doctors, according to a research team from the University of Alabama and Samford University, both in Birmingham.
Candor means sometimes having to say you’re sorry, but it can defuse a potentially litigious situation. That’s surgeon Michael S. Woods’ message in the new edition of his book, “Healing Words: The Power of Apology in Medicine”.
TORONTO—Androgen deficiency in men aged 50 years and older may be associated with an increased risk of death, independent of adiposity and lifestyle choices, a study suggests. This association may be explained, in part, by the metabolic syndrome and elevated markers of inflammation.